Metabolic Correction in Patients Sample with Diabetes: Clinical Outcomes and Costs Reductions
- PMID: 28936369
- PMCID: PMC5604848
Metabolic Correction in Patients Sample with Diabetes: Clinical Outcomes and Costs Reductions
Abstract
Diabetes is a leading cause of mortality and morbidity worldwide. Diabetes complications produce profound impact on patient's quality of life and represent very significant economic cost to patients, their family, the government and society as a whole. Metabolic correction has been proposed as an efficient method to improve clinical outcomes and reduce costs in diabetes. Metabolic correction is a concept that supports health maintenance and promotes the healing processes by improving the body's biochemical-physiological mechanisms. This is done by helping activate the metabolic enzymes necessary to facilitate key physiological pathways. A group of 50 patients followed a simple metabolic correction strategy based on hydration, diet, and magnesium supplementation during a 6 months period. Outcomes measures included laboratory testing, anthropometric measures and medication use including its related costs. Patients had an average weight loss of 9.4 lbs (↓5.0%) from baseline at month 3 and 12 lbs (↓6.4%) at month 6. Waist circumference decreased on average 3.7 inches (↓9.0%) from baseline at month 3 and had further decrease to 5.5 inches (↓13.4%) from baseline at month 6. Laboratory testing of average triglycerides decreased from a baseline of 156.9 to 116.7 (↓25.6%) at month 3 and maintained a reduction of ↓24.2% by month 6. Total cholesterol concentration decreased from a baseline of 181.1 mg/dL to 173.9 (↓4.0%) in month 3 and to 171.1 (↓5.5%) at month 6. Average HgA1c decreased from baseline of 7.17 to 6.52 (↓9.1%) at month 3 and maintained 6.52 at months 6. The atherogenic index decreased from 4.18 at baseline to 3.85 at month 3 (↓7.9%) and then 3.47 (17.0%) at month 6. Medication use and cost was quantified in various ways. The average baseline monthly diabetes medication cost per patient of $124.10 was reduced to $ 78.23 (↓36.7% reduction) at month 3 and to $62.80 (↓49.4% reduction) at month 6. A simple and well structured metabolic correction program that includes a significant educational component, dietary modifications and dietary supplement intake was able to maintain or improve vital signs, anthopometric and laboratory measurements that correlate with improved clinical diabetes and cardiovascular health. This outcome was achieved while decreasing the use medications at month 3 and 6 at significant cost savings.
Keywords: Cost reduction; Diabetes; Diabetes care cost; Diet; Magnesium; Magnesium supplementation; Metabolic Correction.
Figures
Similar articles
-
Improvement in anthropometric parameters after rational dietary intervention in women with Polycystic Ovary Syndrom as the best method to support treatment.Rocz Panstw Zakl Hig. 2017;68(4):409-417. Rocz Panstw Zakl Hig. 2017. PMID: 29280371
-
Metabolic Correction as a tool to improve diabetes type 2 management.Bol Asoc Med P R. 2015 Apr-Jun;107(2):54-9. Bol Asoc Med P R. 2015. PMID: 26434085 Clinical Trial.
-
The effectiveness of web-based programs on the reduction of childhood obesity in school-aged children: A systematic review.JBI Libr Syst Rev. 2012;10(42 Suppl):1-14. doi: 10.11124/jbisrir-2012-248. JBI Libr Syst Rev. 2012. PMID: 27820152
-
Short-term economic impact of body weight change among patients with type 2 diabetes treated with antidiabetic agents: analysis using claims, laboratory, and medical record data.Curr Med Res Opin. 2007 Sep;23(9):2157-69. doi: 10.1185/0300799007X219544. Curr Med Res Opin. 2007. PMID: 17669232 Review.
-
The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence.Tob Use Insights. 2015 Jul 14;8:1-35. doi: 10.4137/TUI.S15628. eCollection 2015. Tob Use Insights. 2015. PMID: 26242225 Free PMC article. Review.
Cited by
-
Chronic alcohol metabolism results in DNA repair infidelity and cell cycle-induced senescence in neurons.Aging Cell. 2023 Feb;22(2):e13772. doi: 10.1111/acel.13772. Epub 2023 Jan 23. Aging Cell. 2023. PMID: 36691110 Free PMC article.
-
Oscillatory pattern of glycemic control in patients with diabetes mellitus.Sci Rep. 2021 Mar 11;11(1):5789. doi: 10.1038/s41598-021-84822-5. Sci Rep. 2021. PMID: 33707491 Free PMC article.
-
Economic burden of diabetes among medicare beneficiaries with cancer.J Pharm Health Serv Res. 2021 Mar 6;12(2):142-151. doi: 10.1093/jphsr/rmab002. eCollection 2021 Jun. J Pharm Health Serv Res. 2021. PMID: 33995607 Free PMC article.
References
-
- WHO. Country and regional data on diabetes. World Health Organization. WHO; 2015. [Retrieved Nov 8, 2015]. from http://www.who.int/diabetes/facts/en/
-
- Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001 Dec 13;414(6865):782–7. - PubMed
-
- CMS. National Health Expenditure Projections, 2014–24: Spending Growth Faster Than Recent Trends. Health Affairs CMS. 2015 Jul;34(8):1407–1417. - PubMed
-
- WHO Medicine Prices. New WHO report shows that transparency and cooperation help to reduce high prices for new medicines. Copenhagen: WHO; 2015. [Retrieved Nov 8, 2015]. from http://0x9.me/DqJKO.
Grants and funding
LinkOut - more resources
Full Text Sources